Time to celebrate!
Our dear colleague and friend Bert Kwanten successfully defended his PhD. In his thesis, he used CRISPR−Cas9 screening to identify genes that influence the response to the cancer drug selinexor, which targets XPO1. The results of these screens laid the foundation for uncovering a novel allosteric mechanism by which selinexor mediates targeted degradation of XPO1.
It was a pleasure to share this special moment together with all members of our lab.
Time to celebrate! Our dear colleague and friend Bert Kwanten successfully defended his PhD. In his thesis, he used CRISPR−Cas9
What happens when the DD lab steps out of the work environment? A day full of laughter, challenges, and great
In July 2025, Talia Davids completed her Master’s degree in Biology at KU Leuven. After writing her MSc thesis on
We are proud to highlight that Yannick Aerts recently presented his research at the 13th Annual BELVIR Symposium, titled “Identification
